Step by Step Guide To More Income!
Whether you are just starting to trade or believe you’re never too old to learn new tricks, "How To Master the Retirement Trade" is for you!

From options expert Dave Aquino, this e-book will guide you through the morning trade window bringing profits to newbies and seasoned pros alike.
Get yours now!
Norman Payson, insider at Progyny
Norman Payson Insider Alerts

Get notified the next time Norman Payson buys or sells Progyny stock. Enter your email address below to get our daily insider buying and selling report.

Norman Payson Insider Information

Director of Progyny

Norman Payson is an independent director of Progyny Inc. 

Payson touts a more than 35-year career at the helm of multiple healthcare organizations, both publicly-traded and privately-held equity sponsored institutions. In addition to his position as an independent director with Progyny, Payson also serves as the president and director of NCP Inc., as a director-emeritus for Geisel School of Medicine, and as a chairman for Access Clinical Partners LLC. 

Possibly best known for his expertise in the “payer-provider” divide, Payson has led both providers and payers in cost outcomes and associated healthcare quality. Payson co-founded and served as the CEO of $3 million member health plan Healthsource from 1985 to 1997. In 1998, he became the CEO of Oxford Health Plans, transforming the company into a $6 billion enterprise by the time he left in 2002. 

From 2005 to 2007, he served as chairman of Concentra, one of the largest occupational healthcare companies in the United States. Directly prior to Progyny, Payson spent four years as the CEO of Apria Healthcare, best known as a home infusion and respiratory therapy provider. Since 1997, Payson has been president and director of his family office, NCP, where he performs consulting and personal investment activities. 

Payson currently serves on the boards of a variety of private and nonprofit companies, including City of Hope, HPM National Advisory Board at the Mailman School of Public Health at Columbia, Smile Brands, and USC Schaeffer Center Advisory Board. Additionally, he’s on the board of Kiva Foundation, a private charitable foundation he founded with his wife in 1998. 

Payson earned his B.S. in planetary sciences from the Massachusetts Institute of Technology, and he holds a doctorate in medicine from Dartmouth Medical School. Payson is a California-licensed physician. 

What is Norman Payson's net worth?

The estimated net worth of Norman Payson is at least $230,280.00 as of August 25th, 2021. Mr. Payson owns 6,000 shares of Progyny stock worth more than $230,280 as of January 20th. This net worth approximation does not reflect any other assets that Mr. Payson may own. Learn More.

How do I contact Norman Payson?

The corporate mailing address for Mr. Payson and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]

Has Norman Payson been buying or selling shares of Progyny?

During the last ninety days, Norman Payson has sold $778,938.00 of Progyny stock. Most recently, Norman Payson sold 8,330 shares of the business's stock in a transaction on Wednesday, January 12th. The shares were sold at an average price of $46.52, for a transaction totalling $387,511.60.

Who are Progyny's active insiders?

Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (CEO), and Cheryl Scott (Director).

Are insiders buying or selling shares of Progyny?

In the last twelve months, Progyny insiders bought shares 1 times. They purchased a total of 2,000 shares worth more than $14,060.00. In the last twelve months, insiders at the sold shares 86 times. They sold a total of 2,998,590 shares worth more than $201,908,468.02. The most recent insider tranaction occured on January, 12th when Director Norman Payson sold 8,330 shares worth more than $387,511.60. Insiders at Progyny own 19.4 % of the company.

Information on this page was last updated on 1/12/2022.

Norman Payson Insider Trading History at Progyny

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2022Sell8,330$46.52$387,511.60View SEC Filing Icon  
1/5/2022Sell8,330$46.99$391,426.70View SEC Filing Icon  
12/22/2021Sell8,330$50.62$421,664.60View SEC Filing Icon  
12/15/2021Sell8,330$47.60$396,508.00View SEC Filing Icon  
12/8/2021Sell8,330$50.65$421,914.50View SEC Filing Icon  
12/1/2021Sell8,330$50.13$417,582.90View SEC Filing Icon  
11/23/2021Sell8,130$54.26$441,133.80View SEC Filing Icon  
11/17/2021Sell8,330$63.36$527,788.80View SEC Filing Icon  
11/10/2021Sell8,330$63.18$526,289.40View SEC Filing Icon  
11/3/2021Sell8,330$61.40$511,462.00View SEC Filing Icon  
10/27/2021Sell8,330$60.69$505,547.70View SEC Filing Icon  
10/20/2021Sell8,330$58.74$489,304.20View SEC Filing Icon  
10/13/2021Sell8,330$58.37$486,222.10View SEC Filing Icon  
10/6/2021Sell8,330$56.97$474,560.10View SEC Filing Icon  
9/29/2021Sell8,330$55.45$461,898.50View SEC Filing Icon  
9/22/2021Sell8,330$61.63$513,377.90View SEC Filing Icon  
8/25/2021Sell8,330$51.64$430,161.206,000View SEC Filing Icon  
8/18/2021Sell8,330$43.93$365,936.90View SEC Filing Icon  
8/4/2021Sell8,330$55.56$462,814.806,000View SEC Filing Icon  
7/22/2021Sell8,570$56.20$481,634.00View SEC Filing Icon  
4/22/2021Sell10,000$50.48$504,800.00528,446View SEC Filing Icon  
4/14/2021Sell5,000$49.57$247,850.00528,446View SEC Filing Icon  
4/7/2021Sell5,000$44.93$224,650.00528,446View SEC Filing Icon  
3/30/2021Sell5,000$43.35$216,750.00528,446View SEC Filing Icon  
3/24/2021Sell5,000$48.48$242,400.00528,446View SEC Filing Icon  
3/17/2021Sell5,000$48.14$240,700.00528,446View SEC Filing Icon  
3/3/2021Sell5,000$42.91$214,550.00528,446View SEC Filing Icon  
2/3/2021Sell5,000$47.80$239,000.00528,446View SEC Filing Icon  
1/27/2021Sell5,000$44.91$224,550.00528,446View SEC Filing Icon  
1/20/2021Sell5,000$48.53$242,650.00528,446View SEC Filing Icon  
1/14/2021Sell10,000$45.12$451,200.00528,446View SEC Filing Icon  
1/6/2021Sell5,000$43.30$216,500.00528,446View SEC Filing Icon  
12/29/2020Sell5,000$41.85$209,250.00528,446View SEC Filing Icon  
12/22/2020Sell5,000$40.64$203,200.00528,446View SEC Filing Icon  
12/16/2020Sell5,000$40.67$203,350.00528,446View SEC Filing Icon  
12/9/2020Sell5,500$37.23$204,765.00528,446View SEC Filing Icon  
12/2/2020Sell5,500$36.27$199,485.00528,446View SEC Filing Icon  
11/23/2020Sell16,500$31.43$518,595.00528,446View SEC Filing Icon  
11/9/2020Sell16,500$29.26$482,790.00528,446View SEC Filing Icon  
11/4/2020Sell16,500$26.71$440,715.00528,446View SEC Filing Icon  
10/28/2020Sell16,500$25.13$414,645.00528,446View SEC Filing Icon  
10/21/2020Sell16,500$27.17$448,305.00522,446View SEC Filing Icon  
10/14/2020Sell16,500$29.04$479,160.00522,446View SEC Filing Icon  
10/8/2020Sell33,000$27.79$917,070.00522,446View SEC Filing Icon  
10/1/2020Sell33,000$29.13$961,290.00522,446View SEC Filing Icon  
9/23/2020Sell16,500$27.08$446,820.00522,446View SEC Filing Icon  
9/16/2020Sell16,500$28.85$476,025.00522,446View SEC Filing Icon  
9/9/2020Sell16,500$28.54$470,910.00522,446View SEC Filing Icon  
9/2/2020Sell16,500$28.91$477,015.00522,446View SEC Filing Icon  
8/27/2020Sell33,000$28.58$943,140.00522,446View SEC Filing Icon  
8/19/2020Sell16,500$32.08$529,320.00522,446View SEC Filing Icon  
8/13/2020Sell16,500$29.60$488,400.00522,446View SEC Filing Icon  
8/5/2020Sell16,500$27.19$448,635.00522,446View SEC Filing Icon  
7/29/2020Sell16,500$26.07$430,155.00522,446View SEC Filing Icon  
7/22/2020Sell16,500$25.69$423,885.00522,446View SEC Filing Icon  
7/15/2020Sell16,500$25.47$420,255.00522,446View SEC Filing Icon  
7/8/2020Sell16,500$25.79$425,535.00522,446View SEC Filing Icon  
6/30/2020Sell16,500$25.55$421,575.00522,446View SEC Filing Icon  
6/24/2020Sell16,500$25.65$423,225.00522,446View SEC Filing Icon  
6/18/2020Sell33,000$22.87$754,710.00522,446View SEC Filing Icon  
6/11/2020Sell33,200$22.56$748,992.00
6/3/2020Sell17,000$24.47$415,990.00522,446View SEC Filing Icon  
5/27/2020Sell17,000$24.28$412,760.00522,446View SEC Filing Icon  
5/20/2020Sell17,000$25.59$435,030.00522,446View SEC Filing Icon  
5/13/2020Sell17,500$25.82$451,850.00522,446View SEC Filing Icon  
5/6/2020Sell17,000$22.10$375,700.00522,446View SEC Filing Icon  
4/29/2020Sell17,000$23.21$394,570.00522,446View SEC Filing Icon  
4/22/2020Sell17,000$22.35$379,950.00522,446View SEC Filing Icon  
10/29/2019Sell568,994$16.39$9,325,811.66
See Full Table

Norman Payson Buying and Selling Activity at Progyny

This chart shows Norman Payson's buying and selling at Progyny by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Progyny Company Overview

Progyny logo
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Read More

Today's Range

Now: $38.38
Low: $38.19
High: $40.66

50 Day Range

MA: $50.53
Low: $38.38
High: $64.37

2 Week Range

Now: $38.38
Low: $38.19
High: $68.32

Volume

804,428 shs

Average Volume

925,802 shs

Market Capitalization

$3.47 billion

P/E Ratio

42.64

Dividend Yield

N/A

Beta

1.72
Bezos, Elon Musk and Zuckerberg Betting Big on S.C.G.
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More